mlsanityData to 14 Oct 2026

ChemFixer: Correcting Invalid Molecules to Unlock Previously Unseen Chemical Space

arXiv 2511.13758 ↗First posted 14 Nov 2025cs.LG cs.AIcited by 0

Not on the map. Why?

Abstract (arXiv)

Deep learning-based molecular generation models have shown great potential in efficiently exploring vast chemical spaces by generating potential drug candidates with desired properties. However, these models often produce chemically invalid molecules, which limits the usable scope of the learned chemical space and poses significant challenges for practical applications. To address this issue, we propose ChemFixer, a framework designed to correct invalid molecules into valid ones. ChemFixer is built on a transformer architecture, pre-trained using masking techniques, and fine-tuned on a large-scale dataset of valid/invalid molecular pairs that we constructed. Through comprehensive evaluations across diverse generative models, ChemFixer improved molecular validity while effectively preserving the chemical and biological distributional properties of the original outputs. This indicates that ChemFixer can recover molecules that could not be previously generated, thereby expanding the diversity of potential drug candidates. Furthermore, ChemFixer was effectively applied to a drug-target interaction (DTI) prediction task using limited data, improving the validity of generated ligands and discovering promising ligand-protein pairs. These results suggest that ChemFixer is not only effective in data-limited scenarios, but also extensible to a wide range of downstream tasks. Taken together, ChemFixer shows promise as a practical tool for various stages of deep learning-based drug discovery, enhancing molecular validity and expanding accessible chemical space.

Key facts. No citing papers in the map yet (data through 14 Oct 2026). Builds on 21 of its 72 references that are in the map. First posted on arXiv 14 Nov 2025.

Builds on

21 of 72 references.

References · 21

  1. 2017Attention Is All You Needcited by 60,361
  2. 2018BERT: Pre-training of Deep Bidirectional Transformers for Language Understandingcited by 40,399
  3. 2014Adam: A Method for Stochastic Optimizationcited by 37,240
  4. 2019BART: Denoising Sequence-to-Sequence Pre-training for Natural Language Generation, Translation, and Comprehensioncited by 5,893
  5. 2022Generative Adversarial Networkscited by 5,627
  6. 2016SGDR: Stochastic Gradient Descent with Warm Restartscited by 5,045
  7. 2019SpanBERT: Improving Pre-training by Representing and Predicting Spanscited by 834
  8. 2016Automatic chemical design using a data-driven continuous representation of moleculescited by 765
  9. 2018Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Modelscited by 275
  10. 2018Fr'echet ChemNet Distance: A metric for generative models for molecules in drug discoverycited by 194
  11. 2016Low Data Drug Discovery with One-shot Learningcited by 91
  12. 2017SMILES Enumeration as Data Augmentation for Neural Network Modeling of Moleculescited by 59
9 more
  1. 2021Quantum Generative Models for Small Molecule Drug Discoverycited by 37
  2. 2020Train No Evil: Selective Masking for Task-Guided Pre-Trainingcited by 36
  3. 2022Group SELFIES: A Robust Fragment-Based Molecular String Representationcited by 33
  4. 2021JANUS: Parallel Tempered Genetic Algorithm Guided by Deep Neural Networks for Inverse Molecular Designcited by 32
  5. 2021Generative Chemical Transformer: Neural Machine Learning of Molecular Geometric Structures from Chemical Language via Attentioncited by 20
  6. 2019The Unbearable Weight of Generating Artificial Errors for Grammatical Error Correctioncited by 8
  7. 2023LLamol: A Dynamic Multi-Conditional Generative Transformer for De Novo Molecular Designcited by 6
  8. 2023GraphCL-DTA: a graph contrastive learning with molecular semantics for drug-target binding affinity predictioncited by 4
  9. 2025HybridLinker: Topology-Guided Posterior Sampling for Enhanced Diversity and Validity in 3D Molecular Linker Generationcited by 2

Built on by

Not cited yet.